Theratechnologies Inc. Forecast, price target & analysts
Theratechnologies Inc. Target price 2026 - Analyst rating & recommendation
Theratechnologies Inc. Classifications & Recommendation
Theratechnologies Inc. Price Target
| Target Price | $3.95 |
| Price | $3.39 |
| Potential |
16.63%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Theratechnologies Inc. 2027 .
The average Theratechnologies Inc. target price is $3.95.
This is
16.63%
register free of charge
$5.34
57.54%
register free of charge
$2.69
20.57%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend Theratechnologies Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Theratechnologies Inc. stock has an average upside potential 2027 of
16.63%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Nov '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 85.87 | 83.87 |
| 5.03% | 2.33% | |
| EBITDA Margin | 11.19% | 14.73% |
| 212.82% | 31.62% | |
| Net Margin | -9.68% | -3.95% |
| 66.98% | 59.18% |
6 Analysts have issued a sales forecast Theratechnologies Inc. 2025 . The average Theratechnologies Inc. sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Theratechnologies Inc. EBITDA forecast 2025. The average Theratechnologies Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Theratechnologies Inc. Analysts have issued a net profit forecast 2025. The average Theratechnologies Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Nov '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.17 | -0.07 |
| 81.32% | 58.82% | |
| P/E | negative | |
| EV/Sales | 2.12 |
5 Analysts have issued a Theratechnologies Inc. forecast for earnings per share. The average Theratechnologies Inc. EPS is
This results in the following potential growth metrics and future valuations:
Theratechnologies Inc....
Current Theratechnologies Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RESEARCH CAPITAL CORPORATION |
Locked
➜
Locked
|
Locked | Jul 03 2025 |
| RESEARCH CAPITAL CORPORATION |
Locked
➜
Locked
|
Locked | Jul 02 2025 |
| LEEDE JONES GABLE |
Locked
➜
Locked
|
Locked | Apr 14 2025 |
| LEEDE JONES GABLE |
Locked
➜
Locked
|
Locked | Apr 13 2025 |
| RESEARCH CAPITAL CORPORATION |
Locked
➜
Locked
|
Locked | Mar 26 2025 |
| RESEARCH CAPITAL CORPORATION |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
| LEEDE JONES GABLE |
Locked
➜
Locked
|
Locked | Feb 25 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
RESEARCH CAPITAL CORPORATION:
Locked
➜
Locked
|
Jul 03 2025 |
|
Locked
RESEARCH CAPITAL CORPORATION:
Locked
➜
Locked
|
Jul 02 2025 |
|
Locked
LEEDE JONES GABLE:
Locked
➜
Locked
|
Apr 14 2025 |
|
Locked
LEEDE JONES GABLE:
Locked
➜
Locked
|
Apr 13 2025 |
|
Locked
RESEARCH CAPITAL CORPORATION:
Locked
➜
Locked
|
Mar 26 2025 |
|
Locked
RESEARCH CAPITAL CORPORATION:
Locked
➜
Locked
|
Mar 25 2025 |
|
Locked
LEEDE JONES GABLE:
Locked
➜
Locked
|
Feb 25 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
